arrow
J

Jessica S Little

Brigham and Women's Hospital
H指数:13
被引数:994

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corticosteroid Therapy and Long-Term Outcomes of Post-Infectious Inflammatory Syndrome in Non-HIV Immunosuppressed Cryptococcal Meningitis: A Multicenter Case Series

糖皮质激素治疗对非HIV免疫抑制状态下隐球菌性脑膜炎患者感染后炎症综合征的长期结局:一项多中心病例系列研究

2026-01-011
PRE
Expression of HLA-B*35 is Associated with an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-based Hematopoietic Cell Transplantation

HLA-B*35的表达与PTCy-based造血细胞移植后巨细胞病毒(CMV)病毒血症及临床显著CMV感染风险的增加相关。

2025-09-210
PRE
Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic and Viral Characteristics and Response to Dual and Extended Antiviral Therapy

B细胞耗竭患者中慢性SARS-CoV-2感染:免疫学及病毒学特征以及对联合和延长抗病毒治疗的反应

2025-09-014
PRE
Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study
2025-01-280
PRE
Expression of HLA-B*35 Is Associated with an Increased Risk of CMV Viremia and Clinically Significant CMV Infection in Patients Receiving Ptcy-Based Hematopoietic Cell Transplantation

HLA-B*35的表达与接受Ptcy为基础造血细胞移植的患者发生巨细胞病毒(CMV)病毒血症和临床显著CMV感染风险增加相关。

BLOOD
IF23.1
2024-11-050
PRE
Early CMV Viral Load Burden Predicts Late Clinically Significant CMV Infections in Patients Receiving Ptcy-Based Hematopoietic Cell Transplantation

早期巨细胞病毒(CMV)病毒载量负担可预测接受Ptcy为基础的造血细胞移植患者晚期临床显著CMV感染。

BLOOD
IF23.1
2024-11-050
PRE
Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survival
2024-09-101
OAAI